In the controversial new treatment for multiple sclerosis, the province will fund clinical trials, where Manitoba will fund around $5million.

The Saskatchewan Premier, Brad Wall and Manitoba Greg Selinger said that they will work in collaboration in the advanced clinical trial research, also known as liberation therapy.

Wall said that they will co-operate with MS patients which is good news for them all over the country.

This new procedure is not available in Canada, and it involves the angioplasty to open veins in the neck, and the procedure is based on the hypothesis of Italian Dr. Zamboni.

The Saskatchewan Health Research Foundation (SHRF) has started a procedure in which they will answer to the question whether the procedure is safe and effective for MS patients or not over the phone.

The Manitoba Health Research Council (MHRC) will start up its formal call proposals after the successful consultancy in SHRF. Manitoba has always been interested in Saskatchewan’s doings.

After the successful research the patients of both Saskatchewan and Manitoba will be able for the treatments.

Wall revealed that some provinces who seek their procedures in abroad are also funding them into monitoring.